Oxidant and antioxidant parameters in the treatment of meningitis

Ali Aycicek1, Akin Iscan, Ozcan Erel

  • 1Pediatric Service, Sanliurfa Children's Hospital, Medical Faculty, Harran University, Sanliurfa, Turkey. ali_aycicek@yahoo.com.tr

Pediatric Neurology
|August 7, 2007
PubMed

Insights

Treatment for bacterial meningitis in children reduces serum oxidative stress but increases oxidative stress in the cerebrospinal fluid. This study highlights the complex impact of treatment on oxidant and antioxidant balance.

Area of Science:

  • Biochemistry
  • Pediatric Infectious Diseases
  • Neurology

Background:

  • Bacterial meningitis is a serious infection affecting children.
  • Oxidative stress plays a role in the pathogenesis of bacterial meningitis.
  • Understanding the impact of treatment on oxidative balance is crucial for patient outcomes.

Purpose of the Study:

  • To evaluate the effects of bacterial meningitis treatment on serum and cerebrospinal fluid oxidant-antioxidant status in children.
  • To compare oxidative and antioxidant markers before and after treatment in pediatric patients.

Main Methods:

  • Collected serum and cerebrospinal fluid from 40 children with bacterial meningitis before and after treatment.
  • Collected serum from 37 healthy children as controls.
  • Assessed levels of total oxidant status, lipid hydroperoxide, oxidative stress index, uric acid, albumin, ceruloplasmin, total antioxidant capacity, vitamin C, total bilirubin, and catalase.

Main Results:

  • Serum oxidative stress markers (total oxidant status, lipid hydroperoxide, oxidative stress index) were significantly lower after treatment compared to before treatment.
  • Cerebrospinal fluid oxidative stress markers were significantly higher after treatment than before treatment.
  • Serum and cerebrospinal fluid antioxidant markers showed variable changes, with some not significantly altered by treatment.

Conclusions:

  • Bacterial meningitis treatment leads to decreased oxidative stress in serum but increased oxidative stress in cerebrospinal fluid in children.
  • The findings suggest a complex interplay between treatment and the oxidant-antioxidant system in the central nervous system during bacterial meningitis recovery.

Related Concept Videos

Bacterial Meningitis I: Introduction01:22

Bacterial Meningitis I: Introduction

Bacterial meningitis is a severe, life-threatening inflammation of the meninges, particularly the pia mater and arachnoid mater, affecting the subarachnoid space, ventricles, and cerebrospinal fluid (CSF). If untreated, it can lead to significant neurological complications or death.Causative AgentsCommon pathogens vary with age and immune status. In adults, major organisms include Streptococcus pneumoniae, Neisseria meningitidis, and Haemophilus influenzae. Streptococcus agalactiae (group B...
Bacterial Meningitis II: Pathophysiology01:26

Bacterial Meningitis II: Pathophysiology

Bacterial meningitis typically begins when pathogens such as Neisseria meningitidis and Streptococcus pneumoniae colonize the nasopharynx and invade the bloodstream. This process is facilitated by bacterial virulence factors, such as polysaccharide capsules, which resist phagocytosis and complement-mediated killing. Less commonly, bacteria reach the central nervous system via contiguous spread from infections like otitis media or sinusitis, through congenital or acquired dural defects, or...
Cryptococcal Meningitis01:27

Cryptococcal Meningitis

Cryptococcal meningitis is a life-threatening opportunistic infection predominantly associated with HIV/AIDS, accounting for over 100,000 deaths annually worldwide. However, it also affects individuals with other forms of immunosuppression, including those undergoing immunosuppressive therapy, organ transplant recipients, patients with innate immunodeficiencies, and individuals with hematological disorders. The infection is caused mainly by Cryptococcus neoformans and Cryptococcus gattii,...
Bacterial Meningitis01:24

Bacterial Meningitis

Bacterial meningitis is a severe infectious disease involving inflammation of the meninges, the protective membranes surrounding the brain and spinal cord. It occurs when pathogenic bacteria cross the blood–brain barrier and enter the cerebrospinal fluid. Common causative organisms include Neisseria meningitidis, Streptococcus pneumoniae, Haemophilus influenzae type b, Listeria monocytogenes, and Escherichia coli K1. The exact route of entry varies by pathogen and host condition.Routes of Entry...
Pneumonia IV: Management01:28

Pneumonia IV: Management

The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Viral Meningitis01:18

Viral Meningitis

Viral meningitis is the most common form of meningitis and is often referred to as aseptic meningitis to indicate the absence of bacterial involvement. It is generally milder than bacterial meningitis, with symptoms including fever, headache, stiff neck, drowsiness, nausea, photophobia, and vomiting. Rarely, more severe manifestations or death may occur. Common causative agents include enteroviruses, particularly coxsackie A and B viruses and echoviruses, all members of the Enterovirus genus...